Modulation of neuropeptide Y receptors for the treatment of obesity
- PMID: 19743896
- DOI: 10.1517/13543770903251722
Modulation of neuropeptide Y receptors for the treatment of obesity
Abstract
Background: Neuropeptide Y (NPY) has been demonstrated to have critical roles in the physiological control of appetite and energy homeostasis through NPY Y1, Y2, Y4 and Y5 receptors. A number of synthetic ligands for NPY receptor subtypes have been developed to date, with Y5 receptor antagonists and Y2 and Y4 receptor agonists advancing into clinical trials.
Methods: A survey of the scientific and patent literature since mid-2006 is presented.
Conclusion: In addition to the specific modulation of respective NPY receptor subtypes, recent investigations have revealed that modulation of multiple NPY receptor subtypes produces additive or even synergistic anti-obesity effects. Development of reliable small molecule Y1, Y2 and Y4 receptor ligands would greatly accelerate investigations and drug discovery.
Similar articles
-
Neuropeptide Y2 receptors as drug targets for the central regulation of body weight.Curr Opin Investig Drugs. 2005 Oct;6(10):1002-11. Curr Opin Investig Drugs. 2005. PMID: 16259221 Review.
-
Characterization of a new neuropeptide Y Y5 agonist radioligand: [125I][cPP(1-7), NPY(19-23), Ala31, Aib32, Gln34]hPP.Neuropeptides. 2004 Aug;38(4):163-74. doi: 10.1016/j.npep.2004.04.007. Neuropeptides. 2004. PMID: 15337369
-
Modeling of neuropeptide receptors Y1, Y4, Y5, and docking studies with neuropeptide antagonist.J Biomol Struct Dyn. 2006 Apr;23(5):497-508. J Biomol Struct Dyn. 2006. PMID: 16494499
-
Molecular characterization of the ligand-receptor interaction of the neuropeptide Y family.J Pept Sci. 2000 Mar;6(3):97-122. doi: 10.1002/(SICI)1099-1387(200003)6:3<97::AID-PSC236>3.0.CO;2-E. J Pept Sci. 2000. PMID: 10759209 Review.
-
Binding of chimeric NPY/galanin peptides M32 and M242 to cloned neuropeptide Y receptor subtypes Y1, Y2, Y4, and Y5.Neuropeptides. 2001 Jun-Aug;35(3-4):148-53. doi: 10.1054/npep.2001.0856. Neuropeptides. 2001. PMID: 11884204
Cited by
-
Receptor-specific recognition of NPY peptides revealed by structures of NPY receptors.Sci Adv. 2022 May 6;8(18):eabm1232. doi: 10.1126/sciadv.abm1232. Epub 2022 May 4. Sci Adv. 2022. PMID: 35507650 Free PMC article.
-
Gut-Brain Endocrine Axes in Weight Regulation and Obesity Pharmacotherapy.J Clin Med. 2014 Jul 15;3(3):763-94. doi: 10.3390/jcm3030763. J Clin Med. 2014. PMID: 26237477 Free PMC article. Review.
-
C-terminal motif of human neuropeptide Y4 receptor determines internalization and arrestin recruitment.Cell Signal. 2017 Jan;29:233-239. doi: 10.1016/j.cellsig.2016.11.003. Epub 2016 Nov 3. Cell Signal. 2017. PMID: 27818291 Free PMC article.
-
Recent advances in the understanding of how neuropeptide Y and α-melanocyte stimulating hormone function in adipose physiology.Adipocyte. 2016 Jul 13;5(4):333-350. doi: 10.1080/21623945.2016.1208867. eCollection 2016 Oct-Dec. Adipocyte. 2016. PMID: 27994947 Free PMC article. Review.
-
Mechanisms of Nausea and Vomiting: Current Knowledge and Recent Advances in Intracellular Emetic Signaling Systems.Int J Mol Sci. 2021 May 28;22(11):5797. doi: 10.3390/ijms22115797. Int J Mol Sci. 2021. PMID: 34071460 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous
